Adalvo Ltd. Pharmadox Healthcare Ltd.
PolandAll drugs from this manufacturer
-
The medicine is used in adults for the treatment of major depressive episodes. It helps to alleviate symptoms such as sadness, internal tension, sleep disturbances, decreased appetite, difficulty concentrating, feelings of worthlessness, or loss of interest.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 5 mg ATC: N06AX26
-
It is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, tension, sleep disturbances, loss of appetite, difficulty concentrating, or loss of interest.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 10 mg ATC: N06AX26
-
The medicine is used in adults for the treatment of major depressive episodes. It helps to alleviate symptoms such as sadness, internal tension, sleep disturbances, decreased appetite, difficulty concentrating, or loss of interest in favorite activities.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 15 mg ATC: N06AX26
-
The medicine is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, tension, sleep disturbances, loss of appetite, difficulty concentrating, or loss of interest.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 20 mg ATC: N06AX26
-
It is used in adults to relieve symptoms of an overactive bladder, such as a sudden urge to urinate, the need to use the toilet more frequently, and loss of bladder control.
Dosage form: tablets, prolonged release
Active substance Dosage mirabegron 50 mg ATC: G04BD12
-
The medicine is used in adults to treat symptoms of an overactive bladder, such as a sudden urge to urinate, frequent urination, and loss of bladder control. In children and adolescents (from 3 to 18 years old), it is used to treat neurogenic detrusor overactivity to increase bladder capacity and limit urinary leakage.
Dosage form: tablets, prolonged release
Active substance Dosage mirabegron 50 mg ATC: G04BD12
-
It is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, anxiety, sleep problems, loss of appetite, difficulty concentrating, or loss of interest.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 5 mg ATC: N06AX26
-
It is used in the treatment of major depressive episodes in adults. It helps alleviate symptoms such as sadness, anxiety, sleep problems, loss of appetite, difficulty concentrating, or loss of interest.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 10 mg ATC: N06AX26
-
The medicine is used to treat major depressive episodes in adults. It helps to alleviate symptoms such as sadness, internal tension, anxiety, sleep disturbances, decreased appetite, difficulty concentrating, feelings of worthlessness, or loss of interest in favorite activities.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 15 mg ATC: N06AX26
-
It is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, internal tension, sleep disturbances, decreased appetite, difficulty concentrating, or loss of interest in favorite activities.
Dosage form: tablets, film-coated
Active substance Dosage vortioxetine 20 mg ATC: N06AX26
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
This medicine is used in adults to treat symptoms of an overactive bladder, such as a sudden urge to urinate, the need to urinate more frequently, and loss of bladder control.
Dosage form: tablets, prolonged release
Active substance Dosage mirabegron 50 mg ATC: G04BD12